• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

From Pandemic Hero to Underrated Stock Star

Biotech Letter

For investors grappling with the classic dilemma of whether to jump into the stock market or wait for a market dip, here’s a compelling solution: healthcare stocks.

These stocks offer the best of both worlds, combining elements of both defensive and growth investments, providing a potential way out of this conundrum.

The defensive nature of healthcare stocks was vividly displayed in 2022, when the Health Care Select Sector SPDR exchange-traded fund (XLV) only saw a minimal decline of 2.1%, significantly outperforming the broader market's 18% slump.

This resilience stems from a simple truth: regardless of economic conditions, people will always require medical care and medications. As a result, healthcare companies tend to experience less volatility in terms of revenue and earnings compared to the overall market.

However, this year has been a different story. Technology and communication services shares have taken the lead, causing healthcare stocks to dip by 2.3%. Meanwhile, the S&P 500 has surged by 8.4% as investors view healthcare as a defensive sector.

Nonetheless, don't overlook the significant growth potential in this sector. In fact, healthcare has consistently delivered an average annual earnings growth rate of 12% since the mid-1980s, surpassing even the tech sector.

This impressive growth has been driven by factors such as aging populations in developed countries, the rising affluence of consumers in emerging markets, and groundbreaking advancements in the treatment of previously incurable conditions.

Interestingly, the recent decline in healthcare stocks has made their valuations more attractive. Currently, healthcare trades at a 5% discount compared to the broader S&P 500, whereas historically it has commanded a premium of around 11%.

Considering this, it's evident that the fundamental outlook for healthcare remains promising, making it an enticing opportunity for investors.

In the realm of defensive downside protection combined with compelling long-term growth prospects, a few notable companies shine brightly.

One standout is Pfizer (PFE), the pharmaceutical titan that truly hit it out of the park during the tumultuous COVID-19 pandemic.

Not only did it swiftly develop and commercialize its highly successful vaccine in collaboration with BioNTech (BNTX), but it also demonstrated an innovative approach that can be leveraged for future drug and vaccine advancements.

The COVID-19 vaccine proved to be an extraordinary cash cow for Pfizer, catapulting their revenue in 2021 and 2022 to double the figures of the previous two years.

Meanwhile, their free cash flow nearly tripled, presenting the company with abundant financial opportunities.

When we examine Pfizer in comparison to its US Big Pharma counterparts like Johnson & Johnson (JNJ), Eli Lilly (LLY), Merck & Co (MRK), AbbVie (ABBV), Bristol Myers Squibb (BMY), Amgen (AMGN), and Gilead Sciences (GILD), though, it becomes evident that this stock is appearing significantly undervalued across various metrics.

A fascinating observation emerges when we consider that Pfizer's revenue in 2022 was 3.5 times higher than that of Eli Lilly, yet Pfizer's market capitalization is $150 billion lower than Lilly's.

Furthermore, Pfizer surpassed Merck and AbbVie in revenue by nearly 2 times while achieving a substantially higher profit margin.

Still, Pfizer's market capitalization of $220 billion is nearly $50 billion lower than AbbVie's and approximately $70 billion lower than Merck's.

These comparisons suggest that Pfizer's stock price is curiously undervalued, presenting an opportunity for growth. However, the market has arrived at a different conclusion.

The rationale behind this perspective lies in the belief that the additional revenues generated by Pfizer through Paxlovid and Comirnaty due to the COVID-19 pandemic are not expected to be a permanent fixture.

As fewer individuals receive COVID vaccinations and require antiviral treatments, the demand for these products is predicted to decrease significantly. Consequently, this perceived compromise in Pfizer's growth trajectory has influenced its valuation in the market.

Moreover, several moneymaking drugs are set to lose patent exclusivity, which again underlines why analysts and the market are reluctant to buy the company's stock.

Rather than opting for a special dividend or engaging in additional stock buybacks, Pfizer's management embarked on an impressive acquisition spree, replenishing the company's drug development pipeline.

Pfizer has been making major moves in the pharmaceutical industry since mid-2021.

In a series of high-profile acquisitions, the company has added some promising drug candidates to its already impressive portfolio. In fact, Pfizer is aiming to generate $20 billion in revenues from its product pipeline by 2030, while adding another $25 billion to the top line through business development.

Some of the notable deals completed by Pfizer include the $2.3 billion acquisition of Trillium Therapeutics, which brought in two CD-47 targeting blood cancer drug candidates.

The company also acquired Arena Pharmaceuticals for $7 billion, gaining access to its late-stage autoimmune candidate Etrasimod.

It then completed an $11.6 billion deal for Biohaven and its lead candidate Nurtec, which is indicated for migraine treatment.

Global Blood Therapeutics was acquired for $5.4 billion, adding the commercial-stage drug Oxbryta to Pfizer's portfolio, which is indicated for sickle cell disease.

Pfizer acquired Reviral for $525 million and gained access to its antiviral therapeutics targeting the respiratory syncytial virus.

In March, Pfizer made another bold move by announcing its intention to acquire Seagen for $43 billion. Seagen is a pioneer in the antibody-drug conjugate space, with a portfolio that includes ADCETRIS, TIVDAK, and PADCEV. These drugs earned $839 million, $451 million, and $63 million, respectively, in 2022.

Despite all these acquisitions and the ambitious revenue targets set by Pfizer, some analysts have expressed doubts about the company's ability to achieve its goals.

This is because Pfizer does not currently have any "mega-blockbuster" drugs in its portfolio, which are drugs that generate more than $15 billion in annual sales.

For instance, Merck's Keytruda and Lilly's Tirzepatide are both expected to generate more than $25 billion in annual sales, while AbbVie's Humira has generated more than $15 billion in annual sales for many years.

Nonetheless, Pfizer remains optimistic and is determined to reach its revenue targets by 2030.

Aside from the splashy acquisitions, Pfizer has exciting prospects on the horizon, promising accelerated revenue growth from its non-COVID products in the latter half of this year. The company is gearing up for a series of key product launches that are set to make waves in the market.

One notable launch is Cibinqo, a breakthrough treatment for eczema. With its approval in January, Pfizer anticipates peak sales of approximately $3 billion.

Later in the year, the company has high hopes for Ritlecitinib, a potential therapy for alopecia, as well as Zavzpret, a migraine therapy that gained approval in March. These innovative products are poised to capture significant market share.

Pfizer's portfolio expansion doesn't stop there.

It has set its sights set on Elranatamab, a promising blood cancer therapy projected to reach peak annual sales of $4 billion.

Additionally, the company plans to introduce a new RSV vaccine and pursue label expansions for Xtandi and Braftovi.

Let's also not forget the potential approval for Etrasimod, a blockbuster-in-waiting that could revolutionize the industry.

Overall, Pfizer emerges as a compelling investment opportunity, presenting a unique blend of defensive strength and promising growth potential, while its valuation remains attractive and aligned with historical levels. While it may require a measure of patience, it's crucial to recognize that this stock won't stay affordable forever. I suggest you buy the dip.

 

pfizer growth

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-16 16:00:192023-05-30 16:21:00From Pandemic Hero to Underrated Stock Star
Mad Hedge Fund Trader

May 16, 2023

Diary, Newsletter, Summary

Global Market Comments
May 16, 2023
Fiat Lux

Featured Trades:

(LAST CHANCE TO ATTEND THE THURSDAY, MAY 18, 2023 TAMPA FLORIDA STRATEGY LUNCHEON)
(LOOKING AT THE LARGE NUMBERS)
(TLT), (TBT) (BITCOIN), (MSTR), (BLOK), (HUT)

 

CLICK HERE to download today's position sheet.

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-16 09:06:072023-05-16 18:39:55May 16, 2023
Mad Hedge Fund Trader

SOLD OUT - Thursday, May 18, 2023 Tampa, Florida Global Strategy Luncheon

Lunch

 

Come join me for lunch at the Mad Hedge Fund Trader’s Global Strategy Update, which I will be conducting in Tampa, Florida on Thursday, May 18, 2023. An excellent meal will be followed by a wide-ranging discussion and an extended question-and-answer period.

I’ll be giving you my up-to-date view on stocks, bonds, currencies, commodities, precious metals, and real estate. And to keep you in suspense, I’ll be throwing a few surprises out there too. Tickets are available for $289.

I’ll be arriving on time and leaving late in case anyone wants to have a one-on-one discussion, or just sit around and chew the fat about the financial markets.

The lunch will be held at a private club in downtown Tampa. The precise location will be emailed with your purchase confirmation.

I look forward to meeting you, and thank you for supporting my research.

To purchase tickets for this luncheon, please click here or click on the Buy Now! button above.

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2023/04/tampa.jpg 794 1408 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-16 09:04:102023-07-03 20:26:21SOLD OUT - Thursday, May 18, 2023 Tampa, Florida Global Strategy Luncheon
Mad Hedge Fund Trader

May 15, 2023

Jacque's Post

 

(MAY 10, 2023, WEBINAR SUMMARY)
 
May 15, 2023
 
 
Hello everyone,
 
Welcome to a new week.    
 
I hope Mother’s Day celebrations went well.  Traditionally, you gave your mother a white flower on Mother’s Day to thank her for all she did.  Now, it’s become commercialised.  I still love the white flower sentiment.  It’s simple and refined and repels the commercial taint that has become ubiquitous.  
 
So, this Post will be a summary of John’s latest webinar, which was conducted last week on May 10, 2023.
  
TITLE:  DEBT CEILING DEBACLE
 
Lunches
 
May 16 Key West Strategy Luncheon
May 18 Tampa, Florida
May 19 Boca Raton, Florida
July 6 New York
July 13 Seminar at Sea On Queen Mary II
July 19 London
 
Trade Alert Performance:
 
40 out of 43 trade alerts are profitable
March 20.85%
April 15.13%
May to date 0.75%
 
2023 year to date 61.76%
120.45% trailing one-year return
48.86% average annualized return
 
Debt ceiling debacle has frozen all markets driving volatility to 2-year lows at $15.
 
Trading volumes shrinking by the day.
 
Summer will present the best buying opportunity of the year.
 
Precious metals and commodities should be at the top of the “BUY” list to cash in on an economic recovery.
 
Be patient.  Let the market come to you.
 
ADVICE:  Take a look at Schwab LEAPS.
 
The Global Economy- Hard, Soft, Hard, Soft
 
Fed raises rates 0.25%.  is this the last move this cycle and is this the last move up in the next two years?
 
Non-farm payrolls jump by 253,000.  Unemployment rate jumped by 3.4% suggesting rate hikes are to come.  (Perhaps the Fed is looking at the wrong numbers as AI is creating jobs faster than the Fed can create unemployment by raising rates and making everything expensive and unaffordable for many)   
 
Fed Financial Stability Report highlights risk to the economy.
 
Tightening of bank lending is a concern, so is commercial real estate with elevated valuations.
 
Europe ekes out 0.1% growth in Q1 versus a 1.1% rate for the U.S.
 
New car loans are in free fall.  Collateral damage from the regional banking crisis, hastening a coming recession.
 
Stocks – Dead Weight – Debt Ceiling
 
The Regional Banking crisis spreads with Phoenix Bank Western Alliance Bancorp (WAL) down a staggering 65% on the week.
 
Consensus (SPY) earnings are currently $220 a share giving expensive price/earnings multiple of 18.77x.
 
According to John, you only need to buy 7 stocks this year.  Apple, Amazon, Google, Meta, Nvidia, and Salesforce.
 
All technical are now flashing red.  Seasonals are now turning strongly against stocks.
Volatility plunges to $15 putting the market to sleep.
 
First half flat, second half strong to take us to 4,800 by year-end.
 
QUESTION:  Is it too late to buy LEAPS?
 
Two Year LEAPS are a good bet.
 
Big tech – all in LEAP territory – 1-2 years out.
 
Netflix – LEAP candidate – 1 year LEAP
 
Nvidia – John’s advice – try a 300-310 LEAP one year out.
 
Commodities in free fall – stocks have been slaughtered.
 
US Steel (X) – 2-year LEAP at the money
 
BONDS
 
Bonds back in buy territory.
 
Bonds are showing default fears.  Yellen warns of economic catastrophe if debt ceiling is not raised.
 
10-year yields back to up 3.55%
 
Keep buying 90-day T-bills – now pushing 5.2% risk-free yield.
 
Still looking like 2.5% yield by end of 2023.
 
Keep buying TLT calls, call spreads, and LEAPS on dips.
 
Junk bonds ETF – JNK and HYG are great high-yield plays.
 
 
FOREIGN CURRENCIES
 
WEAK US$.  Will accelerate on any debt default.  Any strength in the dollar will be temporary.  Look for new lows in the dollar by the end of 2023.
 
Buy FXE, FXY, FXB, FXA on dips.
 
ENERGY AND COMMODITIES
 
The Oil collapse is signaling a recession, as is weakness in all other commodities, even Lithium.
 
Widespread EV adoption is finally making a big dent, as are the price wars there.   Buy USO on dips as an economic recovery play.
 
Buy Caterpillar (CAT)
 
UNG – 2-year LEAP territory
 
FCX - LEAP territory – John expects this stock to be around $100 in two years.
 
PRECIOUS METALS
 
Chile nationalizes the Lithium industry, sending (SQM) and (ALB) into a tailspin.  The official reason for this was to make the industry more efficient.
 
The real reason is so the government can spin off the profits in this exploding industry.
 
Child is the world’s second largest producer of lithium, which is essential for EV batteries.
 
Gold is headed for $3000 by 2024.  It’s resting now.
 
The new drivers are the soon-to-be falling interest rates and the current winter season in crypto.
 
Russia and China are also stockpiling gold to sidestep international sanctions.  A severe short squeeze in copper is developing leading to a massive price spike later in 2023.
 
REAL ESTATE
 
Home prices are still rising, even in worse-hit markets, like San Francisco.
 
Pending Home Sales plunge 5.2%
 
New Home sales pop to 683,000
 
S&P Case Shiller Rises 2% in February – the first time in 9 months.
 
Investors are trying to front-run the next leg of the bull market in residential real estate, which should start when interest rates plunge at year-end.
 
Wishing you all an extraordinary week.
 
Cheers,
Jacque
 
We don’t stop playing because we grow old.
We grow old because we stop playing.
 
UNKNOWN
 
 
 
 
 
 
 
https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-15 22:00:052023-05-22 10:38:40May 15, 2023
Mad Hedge Fund Trader

May 15, 2023

Tech Letter

Mad Hedge Technology Letter
May 15, 2023
Fiat Lux

Featured Trade:

(ACCELERATING TO PROFITS)
(TECH)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-15 15:04:032023-05-15 20:10:19May 15, 2023
Mad Hedge Fund Trader

Accelerating to Profits

Tech Letter

Two decades ago, iPhone didn’t exist — hard to believe — right? As it stands now, US consumers wouldn’t be able to survive an hour outside their house without one.

At least I wouldn’t.

Three decades earlier, no one even owned a computer.

Doesn’t that just mess with your head?

The first personal computer arrived about 40 years ago.

Today, we are hypnotized by our computers and almost unable to get away from them.

What does this all mean, John Thomas?

Intuitively and anecdotally, it feels like technology is progressing faster than ever.

Accelerating technology is the explanation of this driving force, which is aptly called the law of accelerating returns.

Computer chips have become increasingly powerful while costing less. That’s because, over the last five decades, the number of transistors—or the tiny electrical components that perform basic operations—on a single chip has been doubling regularly.

So give it to me in a nutshell, and what does it all mean?  

According to the law of accelerating returns, the pace of technological progress—especially information technology—speeds up exponentially over time because there is a common force driving it forward. Being exponential, as it turns out, is all about evolution.

As this process plays out generation after generation, chaotically yet incrementally, incredible growth takes place.

Civilizations advance by “repurposing” the ideas and breakthroughs of their predecessors. Similarly, each generation of technology builds on the advances of previous generations, and this creates a positive feedback loop of improvements.

The big new idea is that each new generation of technology stands on the shoulders of its predecessors—in this way, improvements in technology enable the next generation of even better technology.

Because each generation of technology improves over the last and even self-corrects, the rate of progress from version to version speeds up.

This acceleration can be measured in the “returns” of the technology—such as speed, efficiency, price-performance, and overall “power”—which improve exponentially too.

As technology becomes more effective, it attracts more attention. The result is a flood of new resources—such as increased R&D budgets, recruiting top talent, etc.—which are directed to further improving the technology.

This wave of new resources triggers a “second level” of exponential growth, where the rate of exponential growth also begins accelerating.

However, limited paradigms won’t grow exponentially forever. They grow until they’ve exhausted their potential, at which point a new paradigm replaces the old one.

This suggests that the horizons for amazingly powerful technologies may be closer than we realize.

We’re only 23 years into the 21st century and the progress has been breathtaking—the global adoption of the Internet, smartphones, high-level robots, and AI that will replace everyone’s job so we can sip tea poolside.

We sequenced the first human genome in 2004 at a cost of hundreds of millions of dollars. Now, machines can sequence 100,000 annually for $20 a genome.

These are just a few examples of the law of accelerating returns driving progress forward. Because the future is approaching much faster than we realize, it’s critical to think exponentially about where we’re headed and how we’ll get there.

Clearly, not every company was built equally, and not every tech firm will be able to take advantage quickly of super shifts in technological prowess.

Unfortunately, harnessing new technology like A.I. absorbs capital, and lots of it.

Companies like Apple and Microsoft are almost $3 trillion and wield generous shareholder return programs.

It could be true that the richest will be able to find a path to supercharge business models with the newest tech.

I do believe in 10 years there will be only 7 tech stocks left on the public markets because they will dwarf in size anything that is even remotely less relevant.

Welcome to tech in 2023.

 

technology accelerating

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-15 15:02:352023-05-31 18:26:03Accelerating to Profits
Mad Hedge Fund Trader

Quote of the Day - May 15, 2023

Tech Letter

“AI doesn’t have to be evil to destroy humanity – if AI has a goal and humanity just happens to come in the way, it will destroy humanity as a matter of course without even thinking about it, no hard feelings.” – Said Founder and CEO of Tesla Elon Musk

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/12/elon-musk-e1696019090338.png 372 380 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-15 15:00:482023-05-15 19:05:07Quote of the Day - May 15, 2023
Mad Hedge Fund Trader

Trade Alert - (TSLA) May 15, 2023 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-15 10:09:582023-05-15 10:09:58Trade Alert - (TSLA) May 15, 2023 - BUY
Mad Hedge Fund Trader

May 14, 2023

Diary, Newsletter, Summary

Global Market Comments
May 14, 2023
Fiat Lux

Featured Trades:

(MARKET OUTLOOK FOR THE WEEK AHEAD, or I’M GOING ON STRIKE!)
(TSLA), (TLT), (AAPL), (BRK/B), (BA), (GOOGL)

 

CLICK HERE to download today's position sheet.

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-15 09:04:092023-05-15 15:03:46May 14, 2023
Mad Hedge Fund Trader

The Market Outlook for the Week Ahead, or I’m Going on Strike!

Diary, Newsletter

I think it’s time for me to go out on strike. I’m downing my tools, tearing up my punch card, and manning a picket line.

I get up at 5:00 AM every morning, well before the sun rises here on the west coast, looking for great low-risk high return trades. But for the last several weeks, there have been none, nada, bupkiss.

I have gotten spoiled over the last few years. The financial crisis, pandemic, recovery, and banking crisis provided me with an endless cornucopia of trading opportunities which doubled my average annualized return from 24% to a nosebleed 48.94%.

Part of the problem is that with a success rate of 90%, so much of the market is now copying my trades so that they are getting harder to execute. That wasn’t a problem when markets were booming. It is when trading volumes have shrunk dramatically, as they have done this year.

At The Economist magazine in London whenever plagiarism was discovered,  they used to say that “Imitation is the sincerest former of flattery.”

There is no doubt that the economy is weakening, as the data has definitively shown over the last two weeks. It appears that after 500 basis points in interest rate rises in a year, the Fed’s harsh medicine is finally starting to work. The debt ceiling crisis, and regional banking crisis are scaring more investors further to the sidelines.

Notice how every stock market rally has become increasingly short-lived? Which all raises a heightened risk of recession.

Economies are like families. All are happy for the same reasons but are unhappy in myriad different ways.

In fact, they provide a generous helping of alphabet soup. If you look very closely, you can find some bay leaves, oregano, black pepper, and lots of V’s, W’s, U’s, and L’s.

Now, let’s play a game and see who can pick the letter that most accurately portrays the current economic outlook.

Here is a code key:

V – The very sharp collapse we saw in 2008 and again in 2020 is followed by an equally sharp recovery. I think it is safe to say we can now toss that one out the window. With technology hyper-accelerating, it is safe to write off the “V” recovery scenario.

W – The sharp recovery that began in October 2022 fails and we see a double dip back to those lows.

U – The economy stays at the bottom for a long time before it finally recovers.

L – The economy collapses and never recovers.

The question is, in which of these forecasts should we invest our hard-earned cash?

For a start, you can throw out the “L”. Every recession flushes out a lot  of financial Cassandras who predict the economy will never recover. They are always wrong. Usually, they know more about marketing newsletters than economics.

I believe what we are seeing play out right now is the “W” scenario. This is the best possible scenario for traders, as it calls for a summer correction in the stock market when we can load the boat a second time. If you missed the October low you will get a second bite of the Apple (AAPL), both literally and figuratively.

If I’m wrong, we will get a “U”, a longer recovery. This cannot be dismissed lightly as the unemployment rate is clearly about to rise.

If I limited the outlook to only four possible scenarios, I’d be kidding you. The truth is far more complicated.

Each industry gets its own letter of the alphabet. Technology, some 27% of total stock market capitalization, gets no letter at all because it is thriving, thanks to the explosion of AI applications. That explains the single-minded pursuit of big tech by investors since January.

Someone asked me last week how long I would continue trading and I cited the example of Warren Buffett, who at 92 is 21 years older than me.

I have since found a better example.

Former Secretary of State under Nixon, Henry Kissinger, turns 100 this week, the only man in the world who President Biden, Vladimir Putin, and President Xi Jinping would immediately take a call from.

During the shuttle diplomacy between Israel and Egypt in 1974, I rode with the Secretary on Air Force One, then an antiquated Boeing 727, which is now in a museum in Seattle. For the rest of that story see below.

He gave me “Henry” privileges, while everyone else had to address him as “Mr. Secretary” because my knowledge of history exceeded that of anyone else then in the White House Press Corps, even those who had degrees in the subject.

It also helped that at that point I had already had six years of experience on the ground in the Middle East. It was all heady stuff for a journalist who at 22 was just starting out.

So, that sets the bar higher for me. The good news for you is that I’ll be sending out my wit, wisdom, and trade alerts for at least another 29 years.

So far in May, I have managed a modest +1.70% profit. My 2023 year-to-date performance is now at an eye-popping +63.45%. The S&P 500 (SPY) is up only a miniscule +8.15% so far in 2023. My trailing one-year return reached a 15-year high at +122.11% versus +6.70% for the S&P 500.

That brings my 15-year total return to +660.64%. My average annualized return has blasted up to +48.94%, another new high, some 2.80 times the S&P 500 over the same period.

Some 41 of my 44 trades this year have been profitable. My last 21 consecutive trade alerts have been profitable.

I initiated only one new trade last week, a long in Tesla (TSLA). That leaves me with my two remaining positions. Those include longs in Tesla and the bond market (TLT), which expires this coming Friday. I now have a very rare 80% cash position due to the lack of high-return, low-risk trades.

Treasury Secretary Yellen Warns of Economic Catastrophe, if the debt ceiling is not raised. Congress has voted 98 times to raise the debt ceiling to $31 trillion over 106 years to pay for money already spent. One-third of this was under the previous president who back then warned that he would default. It’s a grasp for power the House just doesn’t have. There really isn’t such a thing as a debt ceiling which has gained an importance far beyond its original housekeeping intention.

Boeing Lands Blockbuster 300 Plane Order, from Ireland’s Ryan Air worth $40 billion. Europe’s Top budget air carrier is loading up on the once troubled 737 MAX. Keeping buying (BA) on dips, now the world’s largest aircraft manufacturer.

CPI Hits 4.9% YOY, after the 0.40% report for April. It’s still headed in the right direction as far as the Fed is concerned and puts a September cut on the table. Eggs were the leader, up 21.4%, while fuel oil is the laggard, down 20.2%. My own 4% inflation rate forecast by yearend is starting to look conservative. Perish the thought!

 

The Oil Collapse is Signaling a Recession, as is weakness in all other commodities, even lithium. Texas tea has plunged 22% I three weeks to a new two year low at $62. It’s one of the worst performing asset classes of 2023. Widespread EV adoption is finally making a big dent, as are the price wars there. OPEC Plus production cuts were unable to stem the decline. Buy (USO) on dips as an economic recovery play.

Is a Bank Short Selling Ban Coming? The Feds could bar hedge funds from launching raids on small regional bank shares with the aim of taking them to zero. Such a ban was enforced for all banks in 2008.

Elon Musk Appoints New Twitter CEO, removing a major management distraction. Linda Yaccarino is the new CEO of Twitter, poached from her from online advertising at NBC. This is a positive for Tesla, as it frees up the heavy burden of turning around Twitter from Musk, allowing him to devote more time to Tesla. It also reduced the risk that Musk will sell more Tesla shares to finance said turnaround. Guess who just got the worst job in the world? Buy (TSLA) on dips.

Weekly Jobless Claims jump to 264,000, a new 18 month high, providing another recession indicator.

US Budget Deficit Shrinks to $1.5 Trillion, down from a $3 trillion peak during the previous administration. Government Bond selling will drop by a similar amount. That’s still up $130 billion from 2022. Increased tax revenues from a recovering economy is the reason. Buy (TLT) on every dip.

Google Ramps Up AI Effort, launching a new suite of AI tools at its annual developer conference. With a 93% market share in online search (GOOGL) has a lot to defend. The stock popped 4% on the news.

FANGS to Rise 50% by Yearend, says Fundstrat’s ultra-bull Tom Lee. I think he’s right, once the debt ceiling debacle gets out of the way. The contribution of AI is being vastly underestimated.

Berkshire Hathaway (BRK/B) Earnings Soar, with operating earnings up 12.6% in Q1, but Warren Buffet expects business to slow. Many companies now have to unwind big pandemic inventories with aggressive sales, crimping inflation. That’s why Berkshire owns $130 billion in cash and Treasury bills.

My Ten Year View

When we come out the other side of the recession, we will be perfectly poised to launch into my new American Golden Age, or the next Roaring Twenties. The economy decarbonizing and technology hyper-accelerating, creating enormous investment opportunities. The Dow Average will rise by 800% to 240,000 or more in the coming decade. The new America will be far more efficient and profitable than the old.

Dow 240,000 here we come!

On Monday, May 15 at 7:30 AM EST the NY Emore State Manufacturing Index is out.

On Tuesday, May 16 at 6:00 AM, Retail Sales are announced.

On Wednesday, May 17 at 11:00 AM the US Building Permits are printed.

On Thursday, May 18 at 8:30 AM, the Weekly Jobless Claims are announced. We also get the Producer.

On Friday, May 19 at 2:00 PM the University of Baker Hughes Rig Count is released.  

As for me, Egypt and I have a long history together. However, when I first visited there in 1974, they tried to kill me.

I was accompanying US Secretary of State Henry Kissinger on Air Force One as part of his “shuttle diplomacy” between Tel Aviv and Cairo. Every Arab terrorist organization had vowed to shoot our plane down.

When we hit the runway in Cairo, I looked out the window and saw a dozen armored personnel carriers chasing us just down the runway. All on board suddenly got that queasy, gut-churning feeling, except for Henry.

When the plane stopped, they surrounded us, then turned around, pointing their guns outward. They were there to protect us.

The sighs of relief were audible. In a lifetime of heart-rending landings, this was certainly one of the most interesting ones. Those State Department people are such wimps! Henry was nonplussed, as usual.

As a result of the talks Israel eventually handed back Sinai in return for an American guarantee of peace which has held to this day. Egyptian president Anwar Sadat was assassinated by his own bodyguard for his efforts shortly afterwards.

Israel was so opposed to the talks that when I traveled to Tel Aviv, El Al Airline security made sure my luggage got lost. So the Israeli airline gave me $25 to buy replacement clothes until my suitcase was delivered. On that budget, all I could afford were the surplus Israeli army fatigues at the Jerusalem flea market.

A week later, my clothes still had not caught up with me when I boarded the plane with Henry. That meant walking the streets of Cairo in my Israeli army uniform. It would be an understatement to say that I attracted a lot of attention.

I was besieged with offers to buy my clothes. Egypt had lost four wars against Israel in the previous 30 years, and war souvenirs were definitely in short supply.

By the time I left the country, I was stripped bare of all Israeli artifacts, down to my towels from the Tel Aviv Hilton, and boarded the British Airways flight to London wearing a cheap pair of Russian blue jeans I had taken in trade.

Levi Strauss never had a thing to worry about.

The bewitching North African country today is still a prisoner of a medieval religion that has left its people stranded in the Middle Ages. While its GDP has doubled in the last 70 years, so has its population, to 110 million, meaning there has been no improvement per capital income at all in a half century. That is a staggering number for a country that is mostly desert.

In 2019, I took my two teenaged daughters to Egypt to visit the pyramids and ride camels as part of an impromptu trip around the world. My logic then was that at the current rate of climate change, this trip might not be possible in five years.

As it turns out, it was not possible in six months when the pandemic started.

We were immediately picked up by Egyptian Intelligence right at the gate who remembered exactly who I was. It seems they never throw anything out in Egypt.

After a brief interrogation where I disclosed my innocent intentions, they released us. No, I wasn’t working for The Economist anymore. Yes, I was just a retired old man with his children. They even gave us a free ride to the Nile Hilton where I spent my first honeymoon in 1977.

Some people will believe anything! And I never did get that suitcase back.Good luck and good trading!

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

 

 

 

 

 

 

 

 

 

 

 

 

2019 Over Sinai

https://www.madhedgefundtrader.com/wp-content/uploads/2023/05/plane-window.jpg 331 441 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-05-15 09:02:502023-05-15 16:49:18The Market Outlook for the Week Ahead, or I’m Going on Strike!
Page 7 of 13«‹56789›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top